Research - Beijing, Beijing Shi, China
Established in 2006 as a cooperative of experienced and dedicated scientists, Gproan Protein Engineering & Gproan Biotechnologiesis has been committed to the development and production of innovative products and technologies that support the global life science research. By applying Gproan's unique protein engineering technologies, large-scale eukaryotic cell culture and fermentation platforms, Gproan invents, develops and markets a wide array of high-quality, value-priced proteinases and endonucleases. Our novel technologies of recombinant baculovirus expression system and optimized suspension insect cell culture constituted a versatile and rapid virus-like particle based vaccine platform to generate highly immunogenic vaccines. Gproan had developed and commercialized Chinese population oriented cervical cancer vaccine against common and specific strains of HPV, Hand-Foot-Mouth Disease vaccine, combined HCV-HEV vaccines and Influenza vaccines.
Nginx
WordPress.org
Google Tag Manager
Google Font API
Mobile Friendly